✦ LIBER ✦

Clinical measurement of mobility and balance impairments in Huntington's disease: Validity and responsiveness

✍ Scribed by Ashwini K. Rao; Lisa Muratori; Elan D. Louis; Carol B. Moskowitz; Karen S. Marder

Book ID: 116499078
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 134 KB
Volume: 29
Category: Article
ISSN: 0966-6362
DOI: 10.1016/j.gaitpost.2008.11.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical assessment of mobility and bala

Clinical assessment of mobility and balance impairments in pre-symptomatic Huntington's disease

✍ Ashwini K. Rao; Elan D. Louis; Karen S. Marder 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 82 KB

Factors that contribute to balance and m

Factors that contribute to balance and mobility impairments in individuals with Huntington's disease

✍ Cruickshank, Travis; Reyes, Alvaro; Peñailillo, Luis; Thompson, Jennifer; Ziman, 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 230 KB

Deficits in stepping response time are a

Deficits in stepping response time are associated with impairments in balance and mobility in people with Huntington disease

✍ Allon Goldberg; Stacey L. Schepens; Shawna M.E. Feely; James Y. Garbern; Lindsey 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 196 KB

Responsiveness of impairments and disabi

Responsiveness of impairments and disabilities in Parkinson's disease

✍ M. Visser; J. Marinus; A.M. Stiggelbout; J.J. van Hilten 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 90 KB

A clinical classification acknowledging

A clinical classification acknowledging neuropsychiatric and cognitive impairment in Huntington’s disease

✍ Tua Vinther-Jensen,Ida U Larsen,Lena E Hjermind… 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 524 KB

Spectrum of gait impairments in presympt

Spectrum of gait impairments in presymptomatic and symptomatic Huntington's disease

✍ Ashwini K. Rao; Lisa Muratori; Elan D. Louis; Carol B. Moskowitz; Karen S. Marde 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB

## Abstract The purpose of this study was to quantify gait impairments in presymptomatic and symptomatic Huntington's disease (HD) subjects, and examine sensitivity of gait measures. Our sample (n = 65) included presymptomatic mutation carriers (PMC) (n = 15), symptomatic HD subjects (SHD) (n = 30)